We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Gene Mutation Combo Linked to Endometrial Cancer
News

Gene Mutation Combo Linked to Endometrial Cancer

Gene Mutation Combo Linked to Endometrial Cancer
News

Gene Mutation Combo Linked to Endometrial Cancer

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Gene Mutation Combo Linked to Endometrial Cancer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Michigan State University researchers, in collaboration with the Van Andel Institute, have identified a combination of two gene mutations that is linked to endometrial cancer.

"More than 63,000 women are likely to be diagnosed with endometrial cancer this year, making it the most commonly identified type of gynecologic cancer," said Ronald Chandler, an assistant professor of obstetrics, gynecology and reproductive biology in the College of Human Medicine, who led the study.

The research, published in Nature Communications, found that mutations of the ARID1A and PIK3CA genes are frequently found together in the development of endometrial cancer, as well as in endometriosis-associated ovarian cancer. The findings could mean that better, more targeted treatments can be developed to help fight the disease.

ARID1A is a tumor suppressor. When it mutates, chromatin, cellular material that keeps DNA compacted in cells, loses its structure, allowing cancer to spread. PIK3CA is an instructional gene that tells the body to produce certain proteins and leads to uncontrolled growth of cells when it mutates.

Similarly, these same mutations often are found in women who have endometriosis -- a painful condition in which uterine tissue grows outside the uterus -- but many of those affected never develop endometrial cancer.

"We're trying to understand why some women with the same set of mutations get cancer and some don't," Chandler said. "There is something else involved."

Endometrial cancer commonly occurs in women after menopause, suggesting that other factors, such as hormonal changes, environmental exposures or obesity, could combine with the mutations to trigger cancer.

"The hardest part of our job is figuring out what's causing it," Chandler said. "Is it something in the environment or it is something else? It's a complex process. These are big questions that we're trying to address."

Through a collaborative effort, Chandler's team provided genetic material to Van Andel Institute. VAI researchers then analyzed the samples with a next-generation sequencer, a machine that rapidly sequences the human genome. This helped MSU researchers identify which gene mutations were associated with the cancer.

"Ten years ago, this research would not have been possible," said Marie Adams, VAI's genomics core manager and a study co-author. "Next-generation sequencers are powerful new tools we can use to process large-scale projects and provide actionable results in weeks as opposed to years."

Reference: Mike R. Wilson, et al. (2019) ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion. Nature Communications. DOI: https://doi.org/10.1038/s41467-019-11403-6

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement